Home
Journal Information
About
Aims and Scope
Contacts and Editorial Office
Editorial Board
Editor in Chief
Publisher
Conflicts of Interest
Editorial Policies
Publication Ethics
Nickan Research Institute policy
DISCLAIMER
Open Access
Journal Issues
Current Issue
In Press
Archive
Guidelines
For Authors
For Authors-New
For Reviewers
Peer Review Process in JRIP
Peer Review Process flowchart in JRIP
Authors agreement form
Checklist for review
Editorial Workflow
Publication Ethics and Malpractice Statement
Human and animal right
Informed Consent
Create Account
Login
Please don't use dangerous characters
Title
Author
Abstract
Keywords
First Name
Last Name
Search
eISSN
:
2345-2781
Submit Your Paper
Editorial Board
Aims and Scope
Publisher
Publication Fee
Contact Us
Archive
Indexing Information
Member of
Follower of
J Renal Inj Prev
. 2019;8(3): 204-210. doi:
10.15171/jrip.2019.38
Original
Serum tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and IL-17 levels are associated with disease activity in systemic lupus erythematosus patients with and without nephritis
Mohammadreza Nakhjavani
1
, Sima Abediazar
2
, Amir Ghorbanihaghjo
3
*
, Niloofar Esmaeili
1
, Tala Pourlak
2
, Sepideh Zununi Vahed
2
Cited by CrossRef: 3
1- Paquissi F, Abensur H. The Th17/IL-17 Axis and Kidney Diseases, With Focus on Lupus Nephritis.
Front Med
. 2021;8
[Crossref]
2- Yin R, Xu R, Ding L, Sui W, Niu M, Wang M, Xu L, Wang H, Srirat C, Nozawa K. Circulating IL‐17 Level Is Positively Associated with Disease Activity in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta‐Analysis.
BioMed Research International
. 2021;2021(1)
[Crossref]
3- Richter P, Macovei L, Mihai I, Cardoneanu A, Burlui M, Rezus E. Cytokines in Systemic Lupus Erythematosus—Focus on TNF-α and IL-17.
IJMS
. 2023;24(19):14413
[Crossref]